Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Executive or director change
  3. 4 Open-market sale Chief Scientific Officer sold 14,166 shares at $34.83 ($493,413)
  4. 4 Open-market sale Director sold 340,000 shares at an average $33.84 ($11,504,564)
  5. CT ORDER Other Confidential Order
  6. 8-K Event Material agreement · Agreement ended · New debt or obligation
  7. 10-Q/A Report 10-Q/A
  8. 4 Open-market sale Director sold 250,000 shares at an average $26.68 ($6,670,678)
  9. 8-K Event Material agreement
  10. SC 13G Stake Amended Statement of Ownership
  11. 4/A Derivatives Options or other derivatives
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Other acquisition Director acquired 335,507 shares (other)
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4/A Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 8-K Event Shareholder vote results
  19. 4 Derivatives Options or other derivatives
  20. 10-Q Report Quarterly Report

Page 41 of 47 · 923 filings